Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions

The generic drug market faces higher costs and supply shortages after the Trump administration imposed a broad 10% tariff on Chinese imports. The move came despite a 30-day pause on other proposed tariffs on Canada and Mexico, and China swiftly answered back with retaliatory levies, raising the specter of a trade war.